Korzeniowski O M, Wennersten C, Moellering R C, Sande M A
Antimicrob Agents Chemother. 1978 Mar;13(3):430-4. doi: 10.1128/AAC.13.3.430.
The combination of penicillin plus netilmicin was synergistic in vitro against 28 strains of Streptococcus faecalis and compared favorably with penicillin in combination with gentamicin. Similarly, penicillin plus netilmicin was as effective as penicillin plus gentamicin in the therapy of 67 rabbits with enterococcal endocarditis produced with a streptomycin-susceptible (S) or a streptomycin-resistant (R) strain of S. faecalis. After 5 days of infection, control rabbits had bacterial titers of 10(10) colony-forming units (CFU)/g of vegetation. Those treated with penicillin plus netilmicin had mean titers of 10(5.2) and 10(5.1) CFU/g for S and R strains, respectively, and those treated with penicillin plus gentamicin had mean valve titers of 10(5.8) CFU/g for both strains. After 10 days of therapy, mean valve titers with penicillin plus netilmicin were 10(3.8) and 10(4.7) CFU/g, and with penicillin plus gentamicin they were 10(4.5) and 10(5.4) CFU/g for S and R strains, respectively. Thus, if netilmicin proves to be less toxic than other aminoglycoside antibiotics, it may have potential usefulness in the therapy of enterococcal endocarditis.
青霉素加奈替米星联合用药在体外对28株粪肠球菌具有协同作用,与青霉素加庆大霉素联合用药相比效果更佳。同样,在治疗67只由对链霉素敏感(S)或链霉素耐药(R)的粪肠球菌菌株引起的肠球菌性心内膜炎的兔子时,青霉素加奈替米星与青霉素加庆大霉素的疗效相当。感染5天后,对照兔子赘生物中的细菌滴度为10(10) 菌落形成单位(CFU)/克。用青霉素加奈替米星治疗的兔子,对于S菌株和R菌株,平均滴度分别为10(5.2) 和10(5.1) CFU/克,而用青霉素加庆大霉素治疗的兔子,两种菌株的瓣膜平均滴度均为10(5.8) CFU/克。治疗10天后,青霉素加奈替米星治疗的瓣膜平均滴度,对于S菌株和R菌株分别为10(3.8) 和(10(4.7) CFU/克,而青霉素加庆大霉素治疗的分别为10(4.5) 和10(5.4) CFU/克。因此,如果奈替米星被证明比其他氨基糖苷类抗生素毒性更小,它可能在肠球菌性心内膜炎的治疗中具有潜在用途。